SCHEMBL15058631

SCHEMBL15058631

CC(C)[C@H](NC(=O)O)C(=O)N1C[C@@H](O)C[C@H]1c1ncc(-c2ccc(Br)cc2)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.53
CYP3A4 P08684 4/20 0.53
KCNH2 Q12809 3/20 0.53
NR1I2 O75469 2/20 0.53
ABCB11 O95342 1/20 0.53
OPRK1 P41145 1/20 0.53
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 1/20 0.47
VHL P40337 9/20 0.40
ELOC Q15369 8/20 0.40
ELOB Q15370 8/20 0.40
PRCP P42785 2/20 0.38
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15060446 1.00 CYP2C9 (0.53) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL6126397 0.92 CYP2C9 (0.47) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL19323294 0.91 CYP3A4 (0.65) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL12098734 0.90 CYP3A4 (0.52) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL12098424 0.90 CYP3A4 (0.52) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL3342572 0.89 CYP3A4 (0.68) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL3344840 0.89 CYP3A4 (0.68) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL15058555 0.89 CYP3A4 (0.55) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL15057573 0.89 CYP3A4 (0.55) CYP2C9CYP3A4KCNH2NR1I2ABCB11
SCHEMBL21877123 0.88 VHL (0.50) CYP2C9CYP3A4KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013095275-A1 NOVEL HEPATITIS C VIRUS INHIBITORS MEDIVIR AB (SE) 2013-06-27 WO disclosed